Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 982 | 1215 | 1067 | 1321 | 1593 |
Fund Return | 6.32% | -1.77% | 21.47% | 2.18% | 5.72% | 4.77% |
Place in category | 508 | 526 | 445 | 225 | 382 | 242 |
% in Category | 73 | 78 | 71 | 40 | 62 | 62 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VALIC Company I Stock Index | 6.97B | 20.68 | 8.74 | 12.64 | ||
VALIC Company I Mid Cap Index | 3.04B | 12.41 | 4.80 | 9.50 | ||
VALIC Company I Science & Technolog | 2.94B | 24.29 | 4.99 | 16.86 | ||
VALIC Company I Growth | 1.77B | 24.14 | 5.23 | 13.93 | ||
VALIC Company I Small Cap Index | 1.17B | 9.25 | -0.42 | 7.64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.61B | 8.18 | 1.45 | 4.94 | ||
Fidelity International Index Inst | 52.9B | 6.96 | 2.81 | 5.35 | ||
Fidelity Series Global ex US Index | 48.18B | 8.52 | 1.64 | 4.77 | ||
Strategic Advisers International I | 42.32B | 8.45 | 1.91 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Msci Eafe Dec24 Ifus 20241220 | - | 3.14 | - | - | |
Novo Nordisk B | DK0062498333 | 2.03 | 752.3 | +0.93% | |
ASML Holding | NL0010273215 | 1.78 | 646.00 | -0.92% | |
Nestle | CH0038863350 | 1.41 | 75.96 | 0.00% | |
AstraZeneca | GB0009895292 | 1.29 | 10,488.0 | +0.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review